Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 11/1/2002 First Published: 9/1/2000


1.		Phase II Pilot Study of Phenylbutyrate, Dexamethasone, and Sargramostim (GM-CSF) in Patients With Refractory or Relapsed T(8;21) Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NHLBI				NHLBI-00-H-0156 NCI-171, NCT00006240, 171

Last Modified: 5/22/2008 First Published: 10/6/2006


2.		Phase II Study of Phenylbutyrate and Valganciclovir in Patients With Relapsed or Refractory, Epstein-Barr Virus-Positive Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCSD-050126 ROCHE-VAL-108, NCT00387530

Last Modified: 2/1/2001


3.		Phase I Study of Oral Phenylbutyrate for Refractory Adult Solid Tumors or Lymphoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				J-9616 JHOC-9616, NCI-T95-0017H, NCT00002909, T95-0017

Last Modified: 11/1/2001 First Published: 1/1/1998


4.		Phase I Study of Phenylbutyrate in Patients with Refractory Anaplastic Astrocytoma or Glioblastoma (Summary Last Modified 11/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NABTT-9605 JHOC-NABTT-9605, NCI-T96-0086, NABTT-9605

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute